Related Experiment Video
Updated: Aug 7, 2025

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
Published on: July 2, 2020
Neurosurgical Applications of Magnetic Hyperthermia Therapy
Daniel Rivera1, Alexander J Schupper2, Alexandros Bouras3
1Department of Neurological Surgery, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029, USA; Department of Neurological Surgery, University of Pittsburgh, 200 Lothrop Street, Suite F-158, Pittsburgh, PA 15213, USA; Brain Tumor Nanotechnology Laboratory, UPMC Hillman Cancer Center, 5117 Centre Avenue, Pittsburgh, PA 15232, USA.
Magnetic hyperthermia therapy (MHT) shows promise for brain cancer treatment. While effective in preclinical and clinical studies, further technological advancements are needed for MHT to become a standard therapy.
Area of Science:
- Oncology
- Biomedical Engineering
- Nanotechnology
Background:
- Magnetic hyperthermia therapy (MHT) is a localized thermal ablation technique.
- MHT is being investigated as a treatment for various cancers, including aggressive brain cancers.
- Its potential as an adjuvant therapy alongside conventional treatments is under evaluation.
Purpose of the Study:
- To review the efficacy of MHT in treating brain cancers.
- To assess the role of MHT as an adjuvant therapy.
- To identify areas for technological advancement in MHT.
Main Methods:
- Review of preclinical animal studies on MHT for brain cancer.
- Analysis of clinical data from human glioma patients treated with MHT.
- Evaluation of current MHT technology and its limitations.
Main Results:
- MHT demonstrated a significant antitumor effect in animal models.
- Human glioma patients receiving MHT showed a positive association with overall survival.
- Current MHT technology requires further development for widespread clinical application.
Conclusions:
- MHT is a promising localized cancer treatment with demonstrated efficacy in brain cancer.
- MHT shows potential as an adjuvant therapy, improving survival rates in glioma patients.
- Advancements in MHT technology are crucial for its future integration into brain cancer treatment protocols.
More Related Videos
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
13:41Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
Published on: January 13, 2023